Surgical versus endoscopic management of Boerhaave’s syndrome: a systematic review and meta-analysis

INTRODUCTION: Boerhaave's syndrome, a spontaneous full-thickness oesophageal perforation, is rare but life-threatening, largely because of delayed diagnosis and mediastinal contamination. Despite advances in surgical, endoscopic and perioperative care, the optimal management strategy remains uncertain. This study systematically reviewed outcomes following surgical and non-surgical treatment of Boerhaave's syndrome. METHODS: MEDLINE, Embase and CENTRAL were searched from January 2000 to January 2025 for studies reporting outcomes in adults with confirmed Boerhaave's syndrome. The primary outcome was early mortality (in-hospital or 30-day). Secondary outcomes included leak rate, re-intervention and length of hospital stay. Random-effects meta-analyses were performed. Risk of bias was assessed using ROBINS-I. The review was registered with PROSPERO (CRD42024546970). FINDINGS: Twenty-eight observational studies including 881 patients were analysed (mean age 59.5±14 years; 78% male). Of 870 patients receiving active treatment, 80.5% underwent surgery and 19.5% non-surgical management. Primary repair was most common (52.7%), followed by T-tube repair (14.8%) and oesophagectomy or exclusion-diversion (3.4%). Endoscopic therapy accounted for 8.9% and conservative management for 8.7%. Overall early mortality was 16.3% (95% confidence interval [CI] 12.7-20.6%). Mortality was lowest after endoscopic therapy (12.0%) and primary repair (13.3%), and highest after T-tube repair (27.4%) and oesophagectomy or exclusion-diversion (31.2%). Leak rates were similar between surgical repair and endoscopic therapy, but re-intervention was more frequent after endoscopic treatment (odds ratio 4.55, 95% CI 2.63-7.87). Delayed treatment (>24h) showed a non-significant trend towards higher mortality. CONCLUSIONS: Primary repair remains the cornerstone of management for Boerhaave's syndrome. Endoscopic therapy offers comparable survival but is associated with high re-intervention rates. Early diagnosis and individualised treatment selection are essential.

Authors

Institutions

Publication Details

Journal
Annals of The Royal College of Surgeons of England
Published
2026-04-16
DOI
https://doi.org/10.1308/rcsann.2026.0031
Primary Topic
Esophageal and GI Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Surgical versus endoscopic management of Boerhaave’s syndrome: a systematic review and meta-analysis

T Reback, J Butterworth, S Strong, Y Qureshi et al.
Annals of The Royal College of Surgeons of England
Esophageal and GI Pathology
article

Surgical versus endoscopic management of Boerhaave’s syndrome: a systematic review and meta-analysis

T Reback, J Butterworth, S Strong, Y Qureshi, K Dawas, B Mohammadi
article en

Abstract

INTRODUCTION: Boerhaave's syndrome, a spontaneous full-thickness oesophageal perforation, is rare but life-threatening, largely because of delayed diagnosis and mediastinal contamination. Despite advances in surgical, endoscopic and perioperative care, the optimal management strategy remains uncertain. This study systematically reviewed outcomes following surgical and non-surgical treatment of Boerhaave's syndrome. METHODS: MEDLINE, Embase and CENTRAL were searched from January 2000 to January 2025 for studies reporting outcomes in adults with confirmed Boerhaave's syndrome. The primary outcome was early mortality (in-hospital or 30-day). Secondary outcomes included leak rate, re-intervention and length of hospital stay. Random-effects meta-analyses were performed. Risk of bias was assessed using ROBINS-I. The review was registered with PROSPERO (CRD42024546970). FINDINGS: Twenty-eight observational studies including 881 patients were analysed (mean age 59.5±14 years; 78% male). Of 870 patients receiving active treatment, 80.5% underwent surgery and 19.5% non-surgical management. Primary repair was most common (52.7%), followed by T-tube repair (14.8%) and oesophagectomy or exclusion-diversion (3.4%). Endoscopic therapy accounted for 8.9% and conservative management for 8.7%. Overall early mortality was 16.3% (95% confidence interval [CI] 12.7-20.6%). Mortality was lowest after endoscopic therapy (12.0%) and primary repair (13.3%), and highest after T-tube repair (27.4%) and oesophagectomy or exclusion-diversion (31.2%). Leak rates were similar between surgical repair and endoscopic therapy, but re-intervention was more frequent after endoscopic treatment (odds ratio 4.55, 95% CI 2.63-7.87). Delayed treatment (>24h) showed a non-significant trend towards higher mortality. CONCLUSIONS: Primary repair remains the cornerstone of management for Boerhaave's syndrome. Endoscopic therapy offers comparable survival but is associated with high re-intervention rates. Early diagnosis and individualised treatment selection are essential.

Annals of The Royal College of Surgeons of England
University College London Hospitals NHS Foundation Trust (GB), Hillingdon Hospitals NHS Foundation Trust (GB), University Hospitals Bristol NHS Foundation Trust (GB), University College London (GB)
Good health and well-being
Openalex Percentile: Top 16%
Esophageal and GI Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.